Simultaneous Synthesis of Vitamins D<sub>2</sub>, D<sub>4</sub>, D<sub>5</sub>, D<sub>6</sub>, and D<sub>7</sub> from Commercially Available Phytosterol, β-Sitosterol, and Identification of Each Vitamin D by HSQC NMR
Shiro Komba, Eiichi Kotake-Nara, Wakako Tsuzuki
Metabolites · 2019
doi:10.3390/metabo9060107 (opens in a new tab)
We email you when a new notice or a question about this paper appears.
Abstract
We succeeded in simultaneously synthesizing the vitamin D family, vitamins D<sub>2</sub>, D<sub>4</sub>, D<sub>5</sub>, D<sub>6</sub>, and D<sub>7</sub>, from β-sitosterol, which is sold as a commercially available reagent from Tokyo Chemical Industry Co., Ltd. It is officially sold as a mixture of four phytosterols {β-sitosterol (40−45%), campesterol (20−30%), stigmasterol, and brassicasterol}. Owing to this, we anticipated that, using this reagent, various vitamin D analogs could be synthesized simultaneously. We also synthesized vitamin D<sub>3</sub> from pure cholesterol and analyzed and compared all vitamin D analogs (D<sub>2</sub>, D<sub>3</sub>, D<sub>4</sub>, D<sub>5</sub>, D<sub>6</sub>, and D<sub>7</sub>) by HSQC NMR. We succeeded in clearly demonstrating the difference in the NMR chemical shifts for each vitamin D analog.
Abstract licence: CC BY
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.